Management of Well-Differentiated High-Grade (G3) Neuroendocrine Tumors.
Opinion Statement: In 2017, the World Health Organization (WHO) classification for pancreatic NET was updated to include a new category of well-differentiated high-grade (Ki 67 > 20%) pancreatic tumors (NET G3), distinct from high-grade poorly differentiated neuroendocrine carcinoma (NEC). NET G3 ar...
| Published in: | Current Treatment Options in Oncology Vol. 20; no. 9 |
|---|---|
| Main Authors: | , |
| Format: | review Journal Article |
| Published: |
Springer Nature
Sep2019
|
| Online Access: | View this record in EBSCOhost |